Skip to content
‹ Back to IndustriesHealthcare

Simplify and Speed Up Your COVID-19 Testing Process with LabDash

ALBANY, OREGON – Concept Systems and WVT Laboratory have engineered LabDash, a web-based sample tracking system designed to simplify and speed up the COVID-19 testing process, and are excited to make it available to patients, private sponsors, providers and labs. LabDash has been key in WVT’s ability to have scaled to the highest volume COVID-19…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Pro AV Today on MarketScale.

·
Share
Simplify and Speed Up Your COVID-19 Testing Process with LabDash

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

ALBANY, OREGON – Concept Systems and WVT Laboratory have engineered LabDash, a web-based sample tracking system designed to simplify and speed up the COVID-19 testing process, and are excited to make it available to patients, private sponsors, providers and labs. LabDash has been key in WVT’s ability to have scaled to the highest volume COVID-19 testing lab in Oregon. LabDash also works with the Oregon Health Authority and others to provide fast and acurate COVID-19 testing results.

Quick and accurate testing is paramount to improved diagnosis and treatment of the disease and to generate more positive patient outcomes during the pandemic. LabDash makes this possible by simplifying the patient testing process; collection, receipt at the labs, result notification and reporting.

With individual accounts for patients, healthcare providers, sponsors and labs, LabDash has tailored interfaces for each and drastically reduces the complexity of data collection and reporting, while ensuring data accuracy and privacy throughout the process.

The lifecycle and test kit tracking process of LabDash looks like this:

  • The lab generates and assigns barcodes to providers, sponsors and individual patients who have requested tests. The lab is then empowered to follow their own standard procedures for test kit distribution.
  • Providers and sponsors facilitate testing as needed. Providers and patients enter the barcode and patient information to correlate the two when the sample is collected, and write the patient’s initials on the test tube.
  • When tests arrive back at the lab, lab technician scan each sample barcode into LabDash to mark the sample as “received.” The patient’s initials appear on the screen and the technician verifies that it matches what’s written on the test tube – no more manual entry of information.
  • After processing the samples, lab technicians upload the test results to LabDash. Providers and patients are notified that their results have been uploaded and can instantly view their results. A Clinical Lab Report PDF may be downloaded by providers and patients for reporting, travel, or proof of testing.
  • The lab has access to a full customizable, searchable breakdown of all data for reporting. This includes all patient information, sample collection data, provider information and sponsor information.
  • The lab can create custom transaction reports to monitor performance and throughput. User management and messaging tools also enable customer support.

The benefits of LabDash are clear. Because manual data entry is eliminated, data is more accurate and staff strain is reduced. In addition, paperless data collection and electronic data transfer helps support HIPAA compliance and security.

LabDash empowers easy management and tracking of COVID-19 test kits and simplified reporting and analytics, driving measurable benefits across the healthcare ecosystem.

To sign up today, click here.

###

About LabDash

LabDash simplifies and speeds up the entire COVID-19 testing process for patients, providers, private sponsors, and labs. LabDash was designed and built by Concept Systems in partnership with Willamette Valley Toxicology, with a focus on the entire testing lifecycle from patient sign-ups through testing and results reporting, to billing and invoicing. Concept Systems created an easy process to ensure that customers are able to use the system; Create an account, get a QR code, and show up at the testing site: it’s that easy.

Pro AV Today

Part of this channel

Pro AV Today

Pro AV news, trends, and expert voices for the AV industry

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512